Short-Term Xolair Helps Food Allergy Patients Fast-Track OIT
Omalizumab pretreatment allowed most participants with multiple food allergies to reach OIT maintenance doses while avoiding traditional incremental up-dosing.
Useful takeaways from this story.
Omalizumab pretreatment allowed most participants with multiple food allergies to reach OIT maintenance doses while avoiding traditional incremental up-dosing.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Omalizumab pretreatment allowed most participants with multiple food allergies to reach OIT maintenance doses while avoiding traditional incremental up-dosing.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.